Skip to Main Content

Author Details

Viveka Nand Yadav
2005
28
13
PMIDPaper TitleJournal TitlePublished Year
38039965A road map for the treatment of pediatric diffuse midline glioma.Cancer Cell2024
37802053TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory.Cancer Cell2023
35605606Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.Neuro Oncol2023
37657463Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial.Lancet Oncol2023
37584601Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.Cancer Discov2023
35137228Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma.Neuro Oncol2022
35978801Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine.Front Oncol2022
35021084ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization.Cell Reports2022
34644147Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomas.Sci Transl Med2021
32603316Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma.J Clin Invest2020
32297022Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.Curr Oncol Rep2020
32030483Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.Curr Oncol Rep2020
29660022Molecular ablation of tumor blood vessels inhibits therapeutic effects of radiation and bevacizumab.Neuro Oncol2018
30147849Advances in NKT cell Immunotherapy for Glioblastoma.Journal of Cancer Science and Therapy (discontinued)2018
27542769Survival and Proliferation of Neural Progenitor-Derived Glioblastomas Under Hypoxic Stress is Controlled by a CXCL12/CXCR4 Autocrine-Positive Feedback Mechanism.Clinical Cancer Research2017
28724763Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.Journal of Virology2017
28286975Single vs. combination immunotherapeutic strategies for glioma.Expert Opin Biol Ther2017
27863376CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.Oncotarget2016
25632008Ndfip1 regulates itch ligase activity and airway inflammation via UbcH7.Journal of Immunology2015
25117977Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy.Neoplasia2014
24487564There must be a way out of here: identifying a safe and efficient combination of promoter, transgene, and vector backbone for gene therapy of neurological disease.Molecular Therapy2014
25038230Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity.Cancer Research2014
22732591Species selectivity in poxviral complement regulators is dictated by the charge reversal in the central complement control protein modules.Journal of Immunology2012
20089702Influence of electrostatics on the complement regulatory functions of Kaposica, the complement inhibitor of Kaposi's sarcoma-associated herpesvirus.Journal of Immunology2010
19800319Conformational characterization of human eukaryotic initiation factor 2alpha: a single tryptophan protein.Biochemical and Biophysical Research Communications2009
19640995Mapping of functional domains in herpesvirus saimiri complement control protein homolog: complement control protein domain 2 is the smallest structural unit displaying cofactor and decay-accelerating activities.Journal of Virology2009
18216095Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.Journal of Virology2008
15827200Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8).Journal of Virology2005
  • 1 - 28 of 28

Recommended Authors

Collaborators

University of Michigan-Ann Arbor
Co-authored papers 12
Co-authored papers 7
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Children's Hospital of Philadelphia
Co-authored papers 4
University of Michigan Medical School.
Co-authored papers 4
Co-authored papers 4
University Children's Hospital Zurich
Co-authored papers 4
Co-authored papers 4
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
The Hospital for Sick Children
Co-authored papers 2
USA University of Zurich
Co-authored papers 2
CIMA-Universidad de Navarra
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Ontario Brain Institute
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 2
Co-authored papers 2